S. Wegner

发表

World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing

P. Harrigan, W. Verbiest, B. Larder, 2001, AIDS.

The Development of Artificial Neural Networks to Predict Virological response to Combination HIV Therapy

Brendan Larder, Lidia Ruiz, Andrew Revell, 2007, Antiviral therapy.

Effectiveness of highly-active antiretroviral therapy by race/ethnicity

S. Gange, B. Agan, M. Dolan, 2006, AIDS.

Effect of HAART on Incident Cancer and Noncancer AIDS Events Among Male HIV Seroconverters

S. Cole, J. Chmiel, A. Weintrob, 2008, Journal of acquired immune deficiency syndromes.

The Impact of Nelfinavir Exposure on Cancer Development Among a Large Cohort of HIV-Infected Patients

M. Roediger, K. H. Hullsiek, B. Agan, 2009, Journal of acquired immune deficiency syndromes.

Clinical implications of identifying non-B subtypes of human immunodeficiency virus type 1 infection.

L. Jagodzinski, N. Michael, N. Aronson, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increasing Age at HIV Seroconversion From 18 to 40 Years Is Associated With Favorable Virologic and Immunologic Responses to HAART

M. Roediger, B. Agan, A. Weintrob, 2008, Journal of acquired immune deficiency syndromes.

Performance of the Affymetrix GeneChip HIV PRT 440 Platform for Antiretroviral Drug Resistance Genotyping of Human Immunodeficiency Virus Type 1 Clades and Viral Isolates with Length Polymorphisms

B. Larder, S. Bloor, N. Michael, 1999, Journal of Clinical Microbiology.

Comparisons of Causes of Death and Mortality Rates Among HIV-Infected Persons: Analysis of the Pre-, Early, and Late HAART (Highly Active Antiretroviral Therapy) Eras

Mark R Wallace, Scott Wegner, M. Wallace, 2006, Journal of acquired immune deficiency syndromes.

Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort

J. Mascola, M. Wallace, S. Tasker, 2003, AIDS.

Genomic Organization and Functional Characterization of the Chemokine Receptor CXCR4, a Major Entry Co-receptor for Human Immunodeficiency Virus Type 1*

N. Michael, S. Wegner, P. Ehrenberg, 1998, The Journal of Biological Chemistry.

Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia (*)

M. Goldberg, A. Levy, S. Wegner, 1995, The Journal of Biological Chemistry.

Incidence and risk factors for the occurrence of non‐AIDS‐defining cancers among human immunodeficiency virus‐infected individuals

M. Wallace, B. Agan, D. Blazes, 2005, Cancer.

Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study

K. H. Hullsiek, B. Agan, A. Weintrob, 2009, AIDS.

Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.

B. Agan, A. Weintrob, A. Ganesan, 2009, The Journal of infectious diseases.

Correlates of Human Herpesvirus-8 Seropositivity Among U.S. Military Members Recently Infected With Human Immunodeficiency Virus

M. Wallace, A. Wald, L. Corey, 2003, Sexually transmitted diseases.

Lost in translation: implications of HIV-1 codon usage for immune escape and drug resistance.

D. Birx, F. McCutchan, N. Michael, 2004, AIDS reviews.

A Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutational Pattern Confers Phenotypic Lamivudine Resistance in the Absence of Mutation 184V

K. Hertogs, B. Larder, S. Bloor, 2000, Antimicrobial Agents and Chemotherapy.

Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trial.

K. Hertogs, B. Larder, M. Wallace, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Race and Mental Health Diagnosis Are Risk Factors for Highly Active Antiretroviral Therapy Failure in a Military Cohort Despite Equal Access to Care

Joshua D. Hartzell, G. Wortmann, S. Wegner, 2007, Journal of acquired immune deficiency syndromes.

Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel

J. Mascola, K. Hertogs, B. Larder, 2000, AIDS.

2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings.

B. Gazzard, R. Kaiser, B. Larder, 2021, The Journal of antimicrobial chemotherapy.

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings

Dechao Wang, Shanmugam Saravanan, John Baxter, 2018, The Journal of antimicrobial chemotherapy.

A Comparison of Three Computational Modelling Methods for the Prediction of Virological Response to Combination Hiv Therapy Author's Personal Copy

Brendan Larder, Dechao Wang, Lidia Ruiz, 2022 .

Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007.

Scott Wegner, Vincent Marconi, L. Eberly, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy

A. d’Arminio Monforte, B. Larder, J. Montaner, 2009, Artif. Intell. Medicine.